April sees moderate expansion in Greek manufacturing    Mexico selective tariffs hit $48b of imports    UK's FTSE 100 rises ahead of Fed decision    Microsoft, Brookfield team up for renewable energy projects    EFG Hermes closes EGP 600m senior unsecured note issuance for HSB    Microsoft plans to build data centre in Thailand    Japanese Ambassador presents Certificate of Appreciation to renowned Opera singer Reda El-Wakil    WFP, EU collaborate to empower refugees, host communities in Egypt    Health Minister, Johnson & Johnson explore collaborative opportunities at Qatar Goals 2024    SCZONE leader engages in dialogue on eco-friendly industrial zones initiative with Swiss envoy, UNIDO team    Belarusian Prime Minister visits MAZ truck factory in Egypt    Egypt facilitates ceasefire talks between Hamas, Israel    Al-Sisi, Emir of Kuwait discuss bilateral ties, Gaza takes centre stage    Microsoft to invest $1.7b in Indonesia's cloud, AI infrastructure    Egyptian, Bosnian leaders vow closer ties during high-level meeting in Cairo    AstraZeneca, Ministry of Health launch early detection and treatment campaign against liver cancer    Sweilam highlights Egypt's water needs, cooperation efforts during Baghdad Conference    AstraZeneca injects $50m in Egypt over four years    Egypt, AstraZeneca sign liver cancer MoU    Swiss freeze on Russian assets dwindles to $6.36b in '23    Amir Karara reflects on 'Beit Al-Rifai' success, aspires for future collaborations    Climate change risks 70% of global workforce – ILO    Prime Minister Madbouly reviews cooperation with South Sudan    Ramses II statue head returns to Egypt after repatriation from Switzerland    Egypt retains top spot in CFA's MENA Research Challenge    Egyptian public, private sectors off on Apr 25 marking Sinai Liberation    Debt swaps could unlock $100b for climate action    President Al-Sisi embarks on new term with pledge for prosperity, democratic evolution    Amal Al Ghad Magazine congratulates President Sisi on new office term    Egyptian, Japanese Judo communities celebrate new coach at Tokyo's Embassy in Cairo    Uppingham Cairo and Rafa Nadal Academy Unite to Elevate Sports Education in Egypt with the Introduction of the "Rafa Nadal Tennis Program"    Financial literacy becomes extremely important – EGX official    Euro area annual inflation up to 2.9% – Eurostat    BYD، Brazil's Sigma Lithium JV likely    UNESCO celebrates World Arabic Language Day    Motaz Azaiza mural in Manchester tribute to Palestinian journalists    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Early ADHD treatment may ward off problems in school
Stimulants that treat ADHD play a role in short-term increases in scores, relative to students who didn't take the treatment later on, according to a joint Icelandic/US study
Published in Ahram Online on 26 - 06 - 2012

Research suggests kids who get early treatment for their attention-deficit/hyperactivity disorder don't have as much trouble as those who aren't prescribed medication until age 11 or 12.
Common medications used to treat ADHD include stimulants such as Vyvanse, Ritalin and Concerta.
"Their short-term efficacy in treating the core symptoms of ADHD -- the symptoms of hyperactivity and attention and impulsivity -- that has been established," said Helga Zoega, the lead author on the new study from the Mount Sinai School of Medicine in New York.
"With regard to more functional outcomes, for example academic performance or progress, there's not as much evidence there as to whether these drugs really help the kids academically in the long term," she told Reuters Health.
To try to answer that question, Zoega and colleagues from the United States and Iceland consulted prescription drug records and test scores from Icelandic elementary and middle school students between 2003 and 2008.
Out of more than 13,000 kids registered in the national school system, just over 1,000 were treated with ADHD drugs at some point between fourth and seventh grade - 317 of whom began their treatment during that span.
Kids with no record of an ADHD diagnosis tended to score similarly on the standardised math and language arts tests given in fourth and seventh grade. Those who were medicated for the condition were more likely to have their scores decline over the years - especially when stimulants weren't started until later on.
For math exams in particular, students who started on stimulants within one year of their fourth grade tests had an average score decline of less than one per cent between that and their seventh-grade exam - compared to a more than nine per cent drop for those who didn't get treated until sixth or seventh grade.
The difference was especially clear for girls, Zoega and her colleagues reported Monday in Pediatrics.
According to the Centres for Disease Control and Prevention, parent reports suggest close to one in 10 kids and teens in the US have ever been diagnosed with ADHD, and two-thirds of those with a current diagnosis are treated with medication such as stimulants.
ADHD drugs can come with side effects, including appetite loss, sleep problems and stomach aches.


Clic here to read the story from its source.